Physicians' Academy for Cardiovascular Education

Increases in Cholesterol Efflux Capacity and Changes in HDLSubfractions after Single Ascending Doses of MDCO-216 (apoA1-Milano/POPC)

June 18, 2015

Presentation prepared and held by Dr Herman Kempen (The Medicines Company, Switzerland) in Clinical Breakthroughs: A plethora of new therapeutic targets, May 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images
Increases in Cholesterol Efflux Capacity and Changes in.pdf (1,0MB)Increases in Cholesterol Efflux Capacity.pdf (1,0MB)